What is Swissmedic's official website?

Swissmedic's website is swissmedic.ch

What is Swissmedic's industry?

Swissmedic's industry is Government Administration

Who are Swissmedic's top competitors?

Swissmedic's top competitors are , , , , , ,

Swissmedic company information, Employees & Contact Information

Explore related pages

Swissmedic email format Swissmedic management contacts

Related company profiles:

Swissmedic is the national authorisation and supervisory authority for drugs and medical products. The agency ensures that only highquality, safe and effective medical products are available in Switzerland, thus making an important contribution to the protection of human and animal health.

Employees: 481
Address: Hallerstrasse 7, Bern,3012,switzerland
Industry: Government Administration
NAICS: Public Administration

Justice, Public Order, and Safety Activities

Space Research and Technology

Legal Counsel and Prosecution

Correctional Institutions

Parole Offices and Probation Offices

Fire Protection
Website: swissmedic.ch
Keywords: at….
HQ: Bern
Competitors: Swiss Medical Network, Medinside, FMH Verbindung Schweizer Ärztinnen und Ärzte, Lonza, Federal Office of Public Health FOPH, Hirslanden, pharmaSuisse - Schweizerischer Apothekerverband, Roche, Novartis, Swiss Medtech.

Swissmedic Questions

News

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - the-scientist.com

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) the-scientist.com

Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products - Swissmedic

Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products Swissmedic

Federated learning: a privacy-preserving approach to data-centric regulatory cooperation - Frontiers

Federated learning: a privacy-preserving approach to data-centric regulatory cooperation Frontiers

Novartis given green light for infant anti-malaria drug - SWI swissinfo.ch

Novartis given green light for infant anti-malaria drug SWI swissinfo.ch

Survival analysis of time to reimbursement of novel medicines in five Eurasian countries - Global Health Research and Policy

Survival analysis of time to reimbursement of novel medicines in five Eurasian countries Global Health Research and Policy

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective - ASCO Publications

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective ASCO Publications

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal products - Swissmedic

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal products Swissmedic

Features of chronic urticaria after COVID-19 mRNA vaccine over time | Communications Medicine - Nature

Features of chronic urticaria after COVID-19 mRNA vaccine over time | Communications Medicine Nature

A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Administration - Wiley

A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Administration Wiley

Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015–20): a comparative analysis - The Lancet

Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015–20): a comparative analysis The Lancet

New Online Reality Series with Actor, Comedian Billy Gardell Chronicles Type 2 Diabetes Transformation Journey - PR Newswire

New Online Reality Series with Actor, Comedian Billy Gardell Chronicles Type 2 Diabetes Transformation Journey PR Newswire

Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth - Business Wire

Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth Business Wire

Switzerland’s Dependence on a Diamorphine Monopoly - Frontiers

Switzerland’s Dependence on a Diamorphine Monopoly Frontiers

Regulatory & Beyond 2024 - Swissmedic

Regulatory & Beyond 2024 Swissmedic

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020 - Swissmedic

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020 Swissmedic

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution - Swissmedic

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution Swissmedic

Product groups without an intended medical purpose - Swissmedic

Product groups without an intended medical purpose Swissmedic

Market access for COVID-19 vaccines - Swissmedic

Market access for COVID-19 vaccines Swissmedic

Cannabis for medical purposes - Visible - Swissmedic

Cannabis for medical purposes - Visible Swissmedic

Warning regarding HAVYCO-Vy&Tea slimmers’ tea - Swissmedic

Warning regarding HAVYCO-Vy&Tea slimmers’ tea Swissmedic

Swiss regulator warns against dangerous weight loss products - SWI swissinfo.ch

Swiss regulator warns against dangerous weight loss products SWI swissinfo.ch

Patients’ access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe - The Lancet

Patients’ access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe The Lancet

Access Generic Medicines work-sharing initiative - Therapeutic Goods Administration (TGA)

Access Generic Medicines work-sharing initiative Therapeutic Goods Administration (TGA)

United Kingdom – Switzerland Regulatory Cooperation - GOV.UK

United Kingdom – Switzerland Regulatory Cooperation GOV.UK

Dangerous potency products obtained over the Internet - Swissmedic

Dangerous potency products obtained over the Internet Swissmedic

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulatory bodies? - Public Eye

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulatory bodies? Public Eye

Swissmedic authorises new drug for respiratory disease - SWI swissinfo.ch

Swissmedic authorises new drug for respiratory disease SWI swissinfo.ch

Medicines regulators weigh hope and hype with new Alzheimer’s drugs - SWI swissinfo.ch

Medicines regulators weigh hope and hype with new Alzheimer’s drugs SWI swissinfo.ch

Swiss regulator and media clash over weight-loss drugs - SWI swissinfo.ch

Swiss regulator and media clash over weight-loss drugs SWI swissinfo.ch

Report exposes widespread hygiene issues in Swiss hospitals - SWI swissinfo.ch

Report exposes widespread hygiene issues in Swiss hospitals SWI swissinfo.ch

Switzerland’s drug approval process lags behind Europe - SWI swissinfo.ch

Switzerland’s drug approval process lags behind Europe SWI swissinfo.ch

Swiss implant makers come under the microscope - SWI swissinfo.ch

Swiss implant makers come under the microscope SWI swissinfo.ch

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News - bluewin E-Mail

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News bluewin E-Mail

Emergency vaccine approval not legal option in Switzerland - SWI swissinfo.ch

Emergency vaccine approval not legal option in Switzerland SWI swissinfo.ch

Swiss sound alarm over fake drug imports - SWI swissinfo.ch

Swiss sound alarm over fake drug imports SWI swissinfo.ch

Alarm sounded over illegal diet pills - SWI swissinfo.ch

Alarm sounded over illegal diet pills SWI swissinfo.ch

Personalisierter Hirnstimulator bei Swissmedic registriert - Medinside

Personalisierter Hirnstimulator bei Swissmedic registriert Medinside

Companies like Swissmedic

Top Swissmedic Employees

Jacqueline Maria Rohrbach

n/a

Lucerne, Lucerne, Switzerland, Switzerland

View

2
yahoo.com.hk, upd.ch
Ralf Leipner

Those Who Know Nothing Must Believe…

N/a

View
Roger Tosi

Head Of Enterprise Services At…

Rupperswil, Aargau, Switzerland, Switzerland

View

1
egl.ch
Mirjam Kühne

Scientific Expert At Swissmedic Omcl

Greater Bern Area, Switzerland

View

1
hotmail.com

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Swissmedic company information, Employees & Contact Information

Explore related pages

Company Details

Swissmedic Questions

What is Swissmedic's official website?

What is Swissmedic's LinkedIn profile?

How many employees are working in Swissmedic right now?

What is Swissmedic's industry?

What are Swissmedic's top competitors?

What are Swissmedic's categories?

News

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) - the-scientist.com

Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products - Swissmedic

Federated learning: a privacy-preserving approach to data-centric regulatory cooperation - Frontiers

Novartis given green light for infant anti-malaria drug - SWI swissinfo.ch

Survival analysis of time to reimbursement of novel medicines in five Eurasian countries - Global Health Research and Policy

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective - ASCO Publications

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal products - Swissmedic

Features of chronic urticaria after COVID-19 mRNA vaccine over time | Communications Medicine - Nature

A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Administration - Wiley

Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015–20): a comparative analysis - The Lancet

New Online Reality Series with Actor, Comedian Billy Gardell Chronicles Type 2 Diabetes Transformation Journey - PR Newswire

Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth - Business Wire

Switzerland’s Dependence on a Diamorphine Monopoly - Frontiers

Regulatory & Beyond 2024 - Swissmedic

Illegal imports 2021: Swissmedic seizes significantly more packages than in 2020 - Swissmedic

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution - Swissmedic

Product groups without an intended medical purpose - Swissmedic

Market access for COVID-19 vaccines - Swissmedic

Cannabis for medical purposes - Visible - Swissmedic

Warning regarding HAVYCO-Vy&Tea slimmers’ tea - Swissmedic

Swiss regulator warns against dangerous weight loss products - SWI swissinfo.ch

Patients’ access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe - The Lancet

Access Generic Medicines work-sharing initiative - Therapeutic Goods Administration (TGA)

United Kingdom – Switzerland Regulatory Cooperation - GOV.UK

Dangerous potency products obtained over the Internet - Swissmedic

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulatory bodies? - Public Eye

Swissmedic authorises new drug for respiratory disease - SWI swissinfo.ch

Medicines regulators weigh hope and hype with new Alzheimer’s drugs - SWI swissinfo.ch

Swiss regulator and media clash over weight-loss drugs - SWI swissinfo.ch

Report exposes widespread hygiene issues in Swiss hospitals - SWI swissinfo.ch

Switzerland’s drug approval process lags behind Europe - SWI swissinfo.ch

Swiss implant makers come under the microscope - SWI swissinfo.ch

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News - bluewin E-Mail

Emergency vaccine approval not legal option in Switzerland - SWI swissinfo.ch

Swiss sound alarm over fake drug imports - SWI swissinfo.ch

Alarm sounded over illegal diet pills - SWI swissinfo.ch

Personalisierter Hirnstimulator bei Swissmedic registriert - Medinside

Companies like Swissmedic

Lonza

Swiss Medtech

Novartis

Roche

Fmh Verbindung Schwe...

Pharmasuisse - Schwe...

Federal Office Of Pu...

Hirslanden

Medinside

Swiss Medical Network

Top Swissmedic Employees

Jacqueline Maria Rohrbach

n/a

Ralf Leipner

Those Who Know Nothing Must Believe…

Roger Tosi

Head Of Enterprise Services At…

Mirjam Kühne

Scientific Expert At Swissmedic Omcl

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data